ULK1 and neoplasm: Additionally, both the genetic and pharmacological inhibition of ULK1 led to the inhibition of the proliferation and invasion of human HCC cells, and Ulk1 deletion abrogated the tumor growth in a xenograft mouse model (Xue et al., 2020).